Versum Softens Stance On Merck's $6B Hostile Takeover Bid

Versum told shareholders Friday to reject Merck's $6 billion hostile tender offer that launched earlier this week, but said it will negotiate with the science and technology company to see if...

Already a subscriber? Click here to view full article